The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Share News (PXS)

Share Price Information for Provexis (PXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.585
Bid: 0.57
Ask: 0.60
Change: 0.01 (1.74%)
Spread: 0.03 (5.263%)
Open: 0.575
High: 0.00
Low: 0.00
Prev. Close: 0.575
PXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS SUMMARY: Provexis Directors Buy 4.9 Million Shares

Thu, 07th Jan 2016 17:15

LONDON (Alliance News) - The following is a summary of director dealings reported in London on Thursday.
----------
Nutrition products company Provexis said two of its board members snapped up a combined total of 4.9 million shares.

Finance Director Ian Ford bought 2.8 million shares at 0.286 pence each on Thursday. The purchase takes his holding to 5 million shares equating to an 0.3% stake in Provexis.

The company also said Chairman Dawson Buck bought 2.1 million shares at 0.65p each on Wednesday. This takes his holding to 15 million shares, or a 0.9% stake.

The stock closed up 27% at 0.343p Thursday, one of the best performers on AIM.
----------
Inspirit Energy Holdings said Chief Executive Officer John Gunn bought 5 million shares at a price of 0.395 pence per share Thursday. Following this transaction, Gunn now holds 360 million shares, which represents a 46.23% stake in the renewable product development company. The stock closed down 1.3% at 0.375p Thursday.
----------
PetroNeft Resources said Chief Executive Officer Dennis Francis bought 1.5 million shares at a price of 2.25 pence per share Wednesday. Following this transaction, Francis holds 25.9 million shares, which represents a 3.66% stake in the oil and gas company. The stock closed up 5.5% at 2.40p Thursday.
----------
Sunrise Resources said Chairman Patrick Cheetham bought one million shares at a price of 0.207 pence per share Wednesday. Following this transaction, Cheetham is beneficially interested in 26.7 million shares, representing approximately 3.87% of the issued share capital. Shares in the mineral exploration and development company closed down 12% at 0.176p Thursday.
----------
Emerging markets-focused asset manager Aberdeen Asset Management said Non-Executive Director Richard Mully bought 10,000 shares at a price of 266.8 pence per share Wednesday. Following this transaction, Mully holds 60,000 shares, which represents a 0.004% stake in the firm. Shares closed down 3.1% at 249.98p Thursday.
----------
FTSE 250 infrastructure investor and manager John Laing Group said Non-Executive Director Anne Wade acquired 10,000 shares at 205p each on Thursday. Wade now holds 20,256 shares. The stock closed down 0.6% at 206.00p Thursday.
----------
U and I Group said that Deputy Chief Executive Richard Upton acquired 5,477 shares in the company. The shares were purchased at 231 pence each on Wednesday. Upton now owns 2.9 million shares in the company, equivalent to a 2.284% stake. Shares in the property regeneration company closed up 0.1% at 233.00p Thursday.
----------
Treatt said Chief Executive Officer Daemmon Reeve bought 4,245 shares at a price of GBP1.675 each on Wednesday. Following this transaction, Reeve's total beneficial holding stands at 139,121 shares being 0.26% of the issued share capital. The stock closed up 0.9% at 169.95p Thursday.
----------
Mercantile Investment Trust said Non-Executive Director Angus Lennox bought 5,000 shares at a price of 1,803 pence per share on Wednesday. The purchase is his only holding after being appointed in September. The stock closed down 1.4% at 1,769.00p Thursday.
----------
Distribution specialist Connect Group said Glenn Leech, a divisional manager, sold 12,000 shares at a price of 165 pence per share on Wednesday. Following this transaction, Leech holds 188,951 shares, which represents 0.0766% stake in the firm. The stock closed down 1.5% at 163.00p Thursday.
----------
GLI Finance Interim Chief Executive Officer Andy Whelan bought 43,539 shares 36.39p and 70,000 shares at 36.50p each Wednesday. He now holds 3.8 million shares, or a 1.65% stake. The stock closed down 0.3% at 36.75p Thursday.
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
5 Aug 2012 14:10

Sunday share tips: GKN, Provexis, BP

First-half numbers from specialist engineer GKN beat market expectations, with pre-tax profits leaping 43 per cent. Nigel Stein, chief executive, also gave some upbeat interviews, indicating that, while many of GKN's customers were cautious about the rest of 2012, "no one is pressing alarm buttons"

Read more
31 Jul 2012 11:51

Small caps: IndigoVision, Silence Therapeutics, Air Partner...

Air Partner, a provider of air charter services, has said underlying profit before tax for the year is expected to meet its forecasts. The firm's cost reduction programme is also now nearly complete and will realise 'significant cost savings' in the next financial year, with a one off restructuring

Read more
14 Feb 2012 10:12

Small caps round-up: Provexis, CareTech, Nanoco ...

Sports nutrition specialist Provexis said an industrial scale production of Fruitflow powder, was successfully completed in 2012. Fruitflow is Provexis's tomato extract which inhibits platelet aggregating and therefore reduces the chance of heart disease. Provexis has identified a potential applic

Read more
15 Dec 2011 15:01

Sector movers: Old Mutual boosts life insurers after Nordic sale

Life insurance stocks were on the rise on Thursday afternoon, helped by FTSE 100 savings, investment and insurance group Old Mutual. Shares in Old Mutual roared higher on Thursday after announcing that it is to sell its Nordic business Skandia AB for £2.1bn in an effort to "reduce complexity" and p

Read more
1 Dec 2011 12:40

First half losses grow at Provexis

Medical food and dietary supplement developer Provexis disappointed investors with widened losses for the six months ended 30 September. The share price fell 23.08% to 1.75p by 13:05. The losses, which grew from £1m to £1.5m, came despite revenues doubling from £0.7m to £1.5m after costs rose signi

Read more
17 Jun 2011 09:20

Provexis hurt by R&D costs, acquisition fails to inspire

Medical food and dietary supplement developer Provexis reported a wider pre-tax loss, hurt by increased research and development expenses, while its plans to acquire a sports nutrition products manufacturer failed to inspire investors. For the year ended March 31, Provexis posted a loss before tax

Read more
16 Dec 2010 07:49

Rising R&D costs hurt Provexis

Medical food and dietary supplement developer Provexis said pre-tax losses almost doubled as it increased research and development spending. Investment in R&D increased to £612,171 in the period, up from £289,125 in the same period last year, as the group broadens its product pipeline. The group

Read more
9 Sep 2010 16:23

Provexis to exhibit Fruitflow later this year

The board of functional and medical food company Provexis has set itself the task in the coming year of maximising the commercial opportunity for Fruitflow, its patented tomato extract which aims to improve heart health. The marketing strategy for Fruitflow is now being finalised and the technology

Read more
26 Jul 2010 16:55

Provexis widens Fruitflow approvals

Functional foods developer Provexis has gained approval from the European Food Safety Authority (EFSA) to use its Fruitflow technology in dietary supplements. Fruitflow was already allowed to be used in drinks by the EFSA. Provexis can also use the claim that Fruitflow "helps maintain normal plate

Read more
26 Jul 2010 07:33

Provexis: Fruitflow Gets Further European Food Safety Approval

LONDON (Dow Jones)--Provexis PLC (PXS.LN), a company which focuses on the discovery, development and licensing of scientifically-proven functional food, medical food and dietary supplement technologies, Monday announces a widening of the European Food Safety Authority (EFSA) opinion on the Company's

Read more
22 Jun 2010 07:33

Provexis Raises GBP88,869 In Draw Down Of Funds, Equity Issue

LONDON (Dow Jones)--Provexis PLC (PXS.LN), which focuses on the discovery, development and licensing of scientifically-proven functional food, medical food and dietary supplement technologies, said Tuesday it has raised net proceeds of GBP88,869 by drawing down on its Equity Financing Facility with

Read more
31 Mar 2010 17:07

London close: Up and down day for London

The movements of the blue-chip index looked like they were being directed by the grand old Duke of York on Wednesday, with the market finishing neither up nor down. British Sky Broadcasting (BSkyB) was predictably outraged at the decision by telecoms regulator Ofcom to order it to make its two top

Read more
31 Mar 2010 16:08

Small caps round-up: Provexis, Renew, Source BioSciences...........

Functional foods developer Provexis expects to have net cash of £7m at the end of March 2010. It has also entered into a three-year, £25m equity financing facility provided by Evolution Securities through its subsidiary Darwin Strategic. This could be used to help finance acquisitions. Renew Holdi

Read more
9 Mar 2010 08:45

Provexis surges on test results

Shares in medical food and dietary supplement developer Provexis shot up on Tuesday after it published the results of a trial of its Fruitflow product, which is designed to reduce the risk of heart attack, stroke and venous thrombosis. Fruitflow, a tomato extract which counters unwanted clot forma

Read more
17 Dec 2009 12:03

Small cap round-up: ILX, Ideal Shopping, Provexis...

E-learning company ILX has won three contracts that are expected to produce revenues of more than £0.27m over the life of the contracts. The first contract is to provide project management training to a major government department over a period of three years. The other two contracts are for overse

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.